Has anyone given thought to the collaborative R&D that was undertaken a couple of years ago with Carina Biotech? As we know, the IP derived from that collab along with our ongoing collab with Peter Mac bestowed PTX with CellPryme. The reason I ask is because Carina's Car-T clinical trial in colorectal cancer is now recruiting-
PTX was granted the full rights to the IP and what did Carina gain out of the arrangement, I wonder!? Bec is the stem cell queen plus at the time we had the targeted therapies of PTX-100 and 200 in clinical trials. The technology behind PTX-200 forms the backbone (if you like) of CellPryme. So, I wonder whether our collab imparted technology from our resultant cell therapy (ie. they are using CellPryme manufactured cells in their trial) or whether our collab contributed to the R&D of their colorectal program directly at the time. The collab, of course, was flagged as confidential from the outset... and, certainly, still is.
Btw, PTX-100 was initally trialed with a basket of different solid tumours, inc. colon and/or gastro-intestinal tumours.
- Forums
- ASX - By Stock
- Ann: September 2023 Quarterly Update and Appendix 4C
Has anyone given thought to the collaborative R&D that was...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
-0.001(1.23%) |
Mkt cap ! $32.61M |
Open | High | Low | Value | Volume |
4.0¢ | 4.0¢ | 4.0¢ | $8.006K | 200.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 473434 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 414550 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 473434 | 0.039 |
10 | 1290788 | 0.038 |
2 | 103515 | 0.037 |
5 | 429500 | 0.036 |
5 | 313576 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 414550 | 5 |
0.041 | 66952 | 1 |
0.042 | 200000 | 1 |
0.043 | 300000 | 2 |
0.044 | 210000 | 2 |
Last trade - 10.06am 24/06/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online